MAO-B selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof
US10196345B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 29, 2014 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Aug 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are a series of compounds having the structure of Formula I: for use in the inhibition of MAO and uses thereof for the treatment of a barrier disease, obesity, solid epithelial cell tumor metastasis, diabetes, an auto-immune and inflammatory disease or a cardiometabolic disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.